VLX600 is a novel Iron Chelator Targeting Both Proliferating and Quiescent Cancer Cells. VLX600 is able to potentiate the effect of radiation in tumor spheroids in a synergistic manner. VLX600 is a lipophilic cation-based triazinoindolyl-hydrazone compound and mitochondrial oxidative phosphorylation (OxPhos) inhibitor, with potential antineoplastic activity.

纯度：≥98%

CAS：1622945-04-3